Match each patient's clinical presentation of secondary amenorrhea with the most likely underlying pathophysiological mechanism.
- A -year-old competitive marathon runner with a BMI of presents with months of amenorrhea and a thin endometrial stripe on ultrasound.Suppression of hypothalamic gonadotropin-releasing hormone (GnRH) pulsatility
- A -year-old woman presents with months of amenorrhea and cyclic lower abdominal pain; she had a sharp curettage for retained placental tissue months ago. FSH and LH are normal.Obliteration of the uterine cavity by fibrous adhesions
- A -year-old woman with a history of pelvic radiation presents with months of amenorrhea, severe hot flashes, and dyspareunia. Her FSH is .Accelerated depletion of ovarian follicles leading to estrogen deficiency
- A -year-old woman presents with months of amenorrhea and bilateral galactorrhea. She recently began taking risperidone for bipolar disorder.Loss of tuberoinfundibular dopaminergic inhibition on lactotrophs
Cevap
The marathon runner matches with GnRH suppression, the patient with prior curettage matches with fibrous adhesions, the patient with prior radiation matches with ovarian follicle depletion, and the patient taking risperidone matches with loss of dopaminergic inhibition.
Each clinical vignette provides classic pathognomonic features for a distinct etiology of secondary amenorrhea. The competitive athlete has functional hypothalamic amenorrhea due to GnRH suppression. The patient with prior D&C and normal hormones has structural outflow obstruction (intrauterine synechiae). The patient with prior radiation and high FSH has primary ovarian insufficiency (follicular depletion). The patient on an antipsychotic has hyperprolactinemia due to dopamine receptor antagonism.
Adım Adım Çözüm
Anahtar Kavram
Secondary amenorrhea can result from multiple distinct pathophysiological mechanisms, including structural abnormalities (Asherman syndrome), ovarian failure (primary ovarian insufficiency), hypothalamic suppression (functional hypothalamic amenorrhea), and pituitary disruption (hyperprolactinemia).